Nutritional Evaluation of an EPA-DHA Oil from Transgenic Camelina sativa in Feeds for Post-Smolt Atlantic Salmon (Salmo salar L.)
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Vegetable oils (VO) are possible substitutes for fish oil in aquafeeds but their use is limited by their lack of omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA). However, oilseed crops can be modified to produce n-3 LC-PUFA such as eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids, representing a potential option to fill the gap between supply and demand of these important nutrients. Camelina sativa was metabolically engineered to produce a seed oil with around 15% total n-3 LC-PUFA to potentially substitute for fish oil in salmon feeds. Post-smolt Atlantic salmon (Salmo salar) were fed for 11-weeks with one of three experimental diets containing either fish oil (FO), wild-type Camelina oil (WCO) or transgenic Camelina oil (DCO) as added lipid source to evaluate fish performance, nutrient digestibility, tissue n-3 LC-PUFA, and metabolic impact determined by liver transcriptome analysis. The DCO diet did not affect any of the performance or health parameters studied and enhanced apparent digestibility of EPA and DHA compared to the WCO diet. The level of total n-3 LC-PUFA was higher in all the tissues of DCO-fed fish than in WCO-fed fish with levels in liver similar to those in fish fed FO. Endogenous LC-PUFA biosynthetic activity was observed in fish fed both the Camelina oil diets as indicated by the liver transcriptome and levels of intermediate metabolites such as docosapentaenoic acid, with data suggesting that the dietary combination of EPA and DHA inhibited desaturation and elongation activities. Expression of genes involved in phospholipid and triacylglycerol metabolism followed a similar pattern in fish fed DCO and WCO despite the difference in n-3 LC-PUFA contents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811
(2009) · doi:10.1007/978-0-387-89366-2 · Cited by 790
Betancor, M. B., Sprague, M., Usher, S., Sayanova, O., Campbell, P. J., Napier, J. A., & Tocher, D. R. (2015) · Scientific Reports · doi:10.1038/srep08104 · Cited by 180 · cited 8×
“The DCO feed enhance the deposition of DHA in salmon flesh compared to WCO-fed fish, which contrasted with results obtained with the previous EPA only Camelina oil where DHA levels were similar between fish fed both VO (wildtype and EPA Camelina oils) [14].”
BackgroundMethodResultInfluential
Cited by
Tocher, D., Betancor, M., Sprague, M., Olsen, R., & Napier, J. (2019) · Nutrients · doi:10.3390/nu11010089 · Cited by 615
“9% of diet d [78] Veramaris® oil Atlantic salmon FO 25, 50, 75 and 100% of FO e [55] FO and FM 2–4 and 8–15% of diet [79] Camelina sativa EPA oil Atlantic salmon FO and RO 100% of added oil [48,80] Sea bream (Sparus aurata) FO and RO 100% of added oil [81] Camelina sativa EPA+DHA oil Atlantic salmon FO and RO 100% of…”
BackgroundSelf-citationOliver, L., Dietrich, T., Marañón, I., Villarán, M. C., & Barrio, R. J. (2020) · Resources · doi:10.3390/resources9120148 · Cited by 198
Glencross, B. D., Bachis, E., Betancor, M. B., Calder, P., Liland, N., Newton, R., & Ruyter, B. (2025) · Reviews in Fisheries Science & Aquaculture · doi:10.1080/23308249.2024.2388563 · Cited by 89
“The authors did notably mention that EPA bioconversion to DHA was largely influenced by substrate availability, and that the presence of preformed DHA had little inhibitory effect, which are observations consistent with those reported by Betancor et al. (2016).”
InfluentialSelf-citation
Metadata
- Authors
- Betancor, M. B., Sprague, M., Sayanova, O., Usher, S., Metochis, C., Campbell, P. J., Napier, J. A., & Tocher, D. R.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-07-25
- Volume
- 11
- Issue
- 7
- Pages
- e0159934
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2489939492
- Cited by
- 82
- References
- 3
- FWCI
- 11.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.